357649-93-5
357649-93-5 結(jié)構(gòu)式
基本信息
Histone Acetyltransferase Inhibitor IV, CPTH2
Cyclopentylidene-[4-(4-chlorophenyl)thiazol-2-yl)hydrazone
Cyclopentanone, 2-[4-(4-chlorophenyl)-2-thiazolyl]hydrazone
物理化學(xué)性質(zhì)
常見問題列表
| Target | Value |
|
HAT
() | |
|
Gcn5p
() | |
|
KAT3B
() |
CPTH2 (100 μM; 12, 24, 48 hours) causes a decrease in cell proliferation after as early as 12 h with a further significant reduction after 48 h stimulation.
CPTH2 (100 μM; 12 or 48 hours) causes a comparable drop of the activity in both cell lines.
CPTH2 (100 μM; 48 hours) produces a drastic increase in apoptotic/dead cell population after 48 h.
CPTH2 (100 μM; 12, 24, 48 hours) shows a reduced acetylation of both global AcH3 histone and H3AcK18.
CPTH2 (100 μM; 24, 48 hours) is capable to counteract invasion and migration of ccRCC-786-O cells in culture.
CPTH2 (0.2, 0.5, 1 mM) inhibits the growth of a GCN5 deleted strain and a single catalytic mutant E173H.
CPTH2 (0.6, 0.8 mM; for 24 hours) inhibits histone H3 acetylation in yeast cell cultures.
CPTH2 inhibits the Gcn5p dependent functional network.
Cell Proliferation Assay
| Cell Line: | Papillary thyroid (K1) and clear cell Renal Cell Carcinoma (ccRCC-786-O) cell lines |
| Concentration: | 100 μM |
| Incubation Time: | 12, 24, 48 hours |
| Result: | Caused a decrease in cell proliferation after as early as 12 h with a further significant reduction after 48 h stimulation. |
Cell Viability Assay
| Cell Line: | K1 and ccRCC-786-O cell lines |
| Concentration: | 100 μM |
| Incubation Time: | 24 hours (K1 cell) and 48 hours (ccRCC-786-O cell) |
| Result: | Caused a comparable drop of the activity in both cell lines. |
Apoptosis Analysis
| Cell Line: | ccRCC-786-O cells |
| Concentration: | 100 μM |
| Incubation Time: | 48 hours |
| Result: | Produced a drastic increase in apoptotic/dead cell population after 48 h. |
Western Blot Analysis
| Cell Line: | ccRCC-786-O cells |
| Concentration: | 100 μM |
| Incubation Time: | 12, 24, 48 hours |
| Result: | Showed a reduced acetylation of both global AcH3 histone and H3AcK18. |